Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis

Epidermal growth factor receptor (EGFR) mutation is a reliable and sensitive biomarker for EGFR-TKI therapy in non-small-cell lung cancer (NSCLC). However, detection of EGFR mutation in tissues has obvious limitations. Circulating free DNA (cfDNA) has been reported as an alternative approach for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jie, Shen, Li, Zheng, Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385820/
https://www.ncbi.nlm.nih.gov/pubmed/25201768
http://dx.doi.org/10.1038/srep06269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385820/
https://www.ncbi.nlm.nih.gov/pubmed/25201768
http://dx.doi.org/10.1038/srep06269

Ejemplares similares